MiNK Therapeutics (INKT) Shares Issued (2020 - 2026)
MiNK Therapeutics (INKT) posted Shares Issued of $638013.0 for Q1 2026, down 27.21% sequentially from $876533.0 in Q4 2025, and down 27.86% YoY from $884371.0 in Q1 2025.
MiNK Therapeutics (INKT) Shares Issued (2020 - 2026) Analysis & Trends
MiNK Therapeutics has reported Shares Issued for 7 years, with the latest figure at $638013.0 in Q1 2026.
- Quarterly Shares Issued fell 27.86% year-over-year to $638013.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $638013.0 (down 27.86% YoY) and the FY2025 annual result came in at $876533.0, down 2.06% from the prior year.
- Shares Issued retreated to $638013.0 in Q1 2026 per INKT's latest filing, from $876533.0 in the prior quarter.
- Over five years, Shares Issued peaked at $9.0 million in Q2 2024 and troughed at $638013.0 in Q1 2026.
- A 5-year average of $4.2 million and a median of $3.9 million in 2023 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2025: Shares Issued jumped 161.85% in 2023, then plunged 91.38% in 2025.
- Over 5 years, Shares Issued stood at $6.1 million in 2022, then slumped by 88.7% to $694571.0 in 2023, then advanced by 28.86% to $895002.0 in 2024, then slipped by 2.06% to $876533.0 in 2025, then retreated by 27.21% to $638013.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $638013.0, $876533.0, and $772038.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | MiNK Therapeutics | 60.53 Mn | 60.53 Mn | - | 895,003.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 895,003.00 |
| Jun 30, 2026 | 895,003.00 |
| Mar 31, 2026 | 638,013.00 |
| Mar 31, 2026 | 638,013.00 |
| Dec 31, 2025 | 876,533.00 |
| Dec 31, 2025 | 876,533.00 |
| Sep 30, 2025 | 772,038.00 |
| Sep 30, 2025 | 772,038.00 |
| Jun 30, 2025 | 857,470.00 |
| Jun 30, 2025 | 857,470.00 |
| Mar 31, 2025 | 884,371.00 |
| Mar 31, 2025 | 884,371.00 |
| Dec 31, 2024 | 895,002.00 |
| Dec 31, 2024 | 895,002.00 |
| Sep 30, 2024 | 8.95 Mn |
| Sep 30, 2024 | 8.95 Mn |
| Jun 30, 2024 | 8.99 Mn |
| Jun 30, 2024 | 8.99 Mn |
| Mar 31, 2024 | 8.25 Mn |
| Mar 31, 2024 | 8.25 Mn |